Eduardo Ríos

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

Monica Else, Ana Marín‐Niebla, Fátima De la Cruz et al. · British Journal of Haematology · 2012 · 78 citations

Medicine, Oncology, Pharmacotherapy +10

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Carlos Jiménez‐Cortegana, Natalia Palazón‐Carrión, Alejandro Martı́n et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Life Sciences, Hematology, Immunology +17

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Pau Abrisqueta, Javier Loscertales, María José Terol et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +14

A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study

Lucía Marín-Barrera, Andrés J. Muñoz Martín, Eduardo Ríos et al. · Cancers · 2019 · 32 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14